203 related articles for article (PubMed ID: 28112248)
1. Mechanistic interplay between ceramide and insulin resistance.
Reali F; Morine MJ; Kahramanoğulları O; Raichur S; Schneider HC; Crowther D; Priami C
Sci Rep; 2017 Jan; 7():41231. PubMed ID: 28112248
[TBL] [Abstract][Full Text] [Related]
2. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
3. C16:0-ceramide signals insulin resistance.
Hla T; Kolesnick R
Cell Metab; 2014 Nov; 20(5):703-705. PubMed ID: 25440051
[TBL] [Abstract][Full Text] [Related]
4. Modulation of sphingolipid metabolism with calorie restriction enhances insulin action in skeletal muscle.
Obanda DN; Yu Y; Wang ZQ; Cefalu WT
J Nutr Biochem; 2015 Jul; 26(7):687-95. PubMed ID: 25771159
[TBL] [Abstract][Full Text] [Related]
5. Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.
Gosejacob D; Jäger PS; Vom Dorp K; Frejno M; Carstensen AC; Köhnke M; Degen J; Dörmann P; Hoch M
J Biol Chem; 2016 Mar; 291(13):6989-7003. PubMed ID: 26853464
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance induced by de novo pathway-generated C16-ceramide is associated with type 2 diabetes in an obese population.
Chathoth S; Ismail MH; Alghamdi HM; Zakaria HM; Hassan KA; Alshomimi S; Vatte C; Cyrus C; Alsaif HS; Mostafa A; Shaaban H; Al Ali A
Lipids Health Dis; 2022 Feb; 21(1):24. PubMed ID: 35184720
[TBL] [Abstract][Full Text] [Related]
7. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
9. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
10. Ceramide synthases: Reflections on the impact of Dr. Lina M. Obeid.
Kim JL; Mestre B; Shin SH; Futerman AH
Cell Signal; 2021 Jun; 82():109958. PubMed ID: 33607256
[TBL] [Abstract][Full Text] [Related]
11. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
Stiban J; Perera M
Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
[TBL] [Abstract][Full Text] [Related]
12. CerS1-Derived C
Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
[TBL] [Abstract][Full Text] [Related]
13. Sphingolipid metabolism is a crucial determinant of cellular fate in nonstimulated proliferating Madin-Darby canine kidney (MDCK) cells.
Nieto FL; Pescio LG; Favale NO; Adamo AM; Sterin-Speziale NB
J Biol Chem; 2008 Sep; 283(37):25682-25691. PubMed ID: 18625703
[TBL] [Abstract][Full Text] [Related]
14. Altered sphingolipid metabolism in human endometrial cancer.
Knapp P; Baranowski M; Knapp M; Zabielski P; Błachnio-Zabielska AU; Górski J
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):62-6. PubMed ID: 20226264
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol Downregulates Myocardial de Novo Ceramide Synthesis Pathway in a Rat Model of High-Fat Diet-Induced Obesity.
Charytoniuk T; Sztolsztener K; Bielawiec P; Chabowski A; Konstantynowicz-Nowicka K; Harasim-Symbor E
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216351
[TBL] [Abstract][Full Text] [Related]
16. The role of ceramide in regulating endoplasmic reticulum function.
Zelnik ID; Ventura AE; Kim JL; Silva LC; Futerman AH
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jan; 1865(1):158489. PubMed ID: 31233888
[TBL] [Abstract][Full Text] [Related]
17. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
18. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Ceramide De Novo Synthesis Ameliorates Diet Induced Skeletal Muscles Insulin Resistance.
Kurek K; Mikłosz A; Łukaszuk B; Chabowski A; Górski J; Żendzian-Piotrowska M
J Diabetes Res; 2015; 2015():154762. PubMed ID: 26380311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
